Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02684071 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
A Phase 2 study, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT02684071 is a Phase 2 study that was terminated before completion, run by Nicklaus Children's Hospital f/k/a Miami Children's Hospital. The registered enrollment target is 3 participants.
The verdict
NCT02684071, a Phase 2 study, was terminated before completion, sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research study is to test an experimental treatment method for recurrent or progressive brain tumors in children aged from 0-22 years. The use of methotrexate and chemotherapy (topotecan and cyclophosphamide) is experimental in this study. This means that their use by themselves or together has not been approved by the U.S. Food and Drug Administration for this usage.
Interventions
- DRUG cyclophosphamide
- DRUG topotecan
- DRUG Intra thecal methotrexate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-12-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02684071
The ClinicalTrials.gov registry entry for NCT02684071 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nicklaus Children's Hospital f/k/a Miami Children's Hospital, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which cyclophosphamide is the first listed.
NCT02684071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02684071 about?
NCT02684071 is a clinical study titled "Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors". The purpose of this research study is to test an experimental treatment method for recurrent or progressive brain tumors in children aged from 0-22 years. The use of methotrexate and chemotherapy (topotecan and cyclophosphamide) is experimental in this study. This means that their use by themselves ...
What is the current status of trial NCT02684071?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2016-02. Estimated completion is 2019-12-09.
What interventions are being tested in trial NCT02684071?
The interventions under investigation include: cyclophosphamide (DRUG), topotecan (DRUG), Intra thecal methotrexate (DRUG).
Who is sponsoring clinical trial NCT02684071?
This trial is sponsored by Nicklaus Children's Hospital f/k/a Miami Children's Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.